Published in Cancer Weekly, January 29th, 1996
"The patients in these studies are very sick, many with severely compromised immune systems as the result of unsuccessful chemotherapy," said Lev Verkh, Ph.D., Alpha's Associate Director of Clinical Research. "Incidence of this disease is increasing rapidly and new therapies are urgently needed, since up to 75 percent of non-Hodgkin's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.